Promacta helps patients manage bleeding disorder, GSK study shows
LONDON Patients who received a GlaxoSmithKline drug for chronic immune thrombocytopenic purpura over a six-month period experienced significantly increased platelet counts and reduced bleeding, GSK announced Saturday.
The British drug maker presented data Saturday from RAISE, a phase 3 study of the drug Promacta, also known as Revolade (eltrombopag). Data from the study were presented at the 50th annual meeting of the American Society of Hematology in San Francisco, which ends Tuesday.
GSK said patients receiving the drug were eight times more likely than those using placebo to sustain elevated platelet counts.
The Food and Drug Administration granted accelerated approval to the drug Nov. 20 for treating chronic ITP, a disorder resulting from deficient platelets in the bloodstream, which causes an increased risk of bleeding.
About 60,000 people in the United States have the disease.
“Eltrombopag is the first approved agent to show that generating platelets can be achieved and maintained with an oral therapy,” GSK senior vice president of oncology research and development Paolo Paoletti said in a statement. “With the continued emergence of GSK in oncology, we want patients and physicians to continuously benefit from our dedication to developing truly innovative treatments that can help improve patients’ lives.”
CVS Caremark plans to open location in Tulsa area
TULSA, Okla. CVS Caremark is looking to enter the Tulsa market in 2009, according to a local news report.
The company currently has 34 pharmacy locations in the state, but none that operate in the Tulsa area. According to the report, the company will open two or three stores in that market.
According to the report, one of the stores will be located at the site of a former Bennigan’s restaurant at the northeast corner of 71st Street and Yale Avenue—one of the business intersections in south Tulsa. The current building will be torn down for construction of the pharmacy, which is expected to open in October.
Humana expands MinuteClinic network for TRICARE customers
LOUISVILLE, Ky. Humana Military Healthcare Services, a subsidiary of Humana Inc., has added additional MinuteClinic locations for its TRICARE benefits customers.
Initially, MinuteClinic services were available to beneficiaries in select cities in Oklahoma and Texas beginning in October. Clinics are now available to beneficiaries in the following locations: Boca Raton/West Palm Beach, Fort Lauderdale, Jacksonville, Miami, Orlando and Tampa in Florida; Atlanta, Ga.; Columbia, Greenville/Spartanburg/Anderson, S.C.; and Knoxville and Nashville, Tenn.
“MinuteClinic has been a great addition to our provider network,” said Dave Baker, president of chief executive officer of HMHS. “We are pleased with the success of this relationship and the ability to expand this service to more beneficiaries in the South region.”